Fotemustine Plus Etoposide, Cytarabine and Melphalan (FEAM) as a New Conditioning Regimen for Lymphoma Patients Undergoing Auto-Sct: A Multicenter Feasibility Study

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2009.318
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC